Article
Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo.
Neurobiology of disease - 1 Jul 2020
Gogia Neha, Sarkar Ankita, Mehta Abijeet Singh, Ramesh Nandini, Deshpande Prajakta, Kango-Singh Madhuri, Pandey Udai Bhan, Singh Amit
Abstract excerpt
Amyotrophic Lateral Sclerosis (ALS), a late-onset neurodegenerative disorder characterized by the loss of motor neurons in the central nervous system, has no known cure to-date. Disease causing mutations in human Fused in Sarcoma (FUS) leads to aggressive and juvenile onset of ALS. FUS is a well-conserved protein across different species, which plays a crucial role in regulating different aspects of RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
